Potential of 6′‑hydroxy justicidin B from Justicia procumbens as a therapeutic agent against coronavirus disease 2019
This research highlights both the antiviral efficacy and safety profile of 6'-HJB, underscoring its potential as a novel COVID-19 treatment option. The potential of 6'-HJB was demonstrated using modern scientific methodologies and standards.
Authors
- Min Heui Yoo
- Byoung‐Seok Lee (ORCID: https://orcid.org/0000-0003-4215-6495)
- Kang-Hyun Han (ORCID: https://orcid.org/0000-0001-8187-6837)
- Seungtaek Kim (ORCID: https://orcid.org/0000-0003-3954-5908)
- Jihyun Youm
- Han Young Eom
- Yong‐Bum Kim (ORCID: https://orcid.org/0000-0003-3890-2678)
- Wan‐Jung Im
- Sang-Ho Lee
- Yunha Hwang (ORCID: https://orcid.org/0000-0002-5774-4778)
- Joung‐Wook Seo
- Kyong-Cheol Ko
Institutions
- Institut Pasteur Korea (KR)
- Kyung Hee University (KR)
- Korea Institute of Toxicology (KR)
- Dong-A Pharmaceutical (South Korea) (KR)
- Dong Wha Pharm (South Korea) (KR)
- Korea Research Institute of Bioscience and Biotechnology (KR)
- Sungkyunkwan University (KR)
Publication Details
- Journal
- Phytomedicine
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1016/j.phymed.2024.156014
- Citations
- 1
- Primary Topic
- Plant-derived Lignans Synthesis and Bioactivity
- Type
- article
- Field-Weighted Citation Impact
- 0.23
Funders
- Ministry of Science, ICT and Future Planning
- National Research Foundation of Korea
- Ministry of Science ICT and Future Planning
- Ministry of Science and ICT, South Korea